Billionaire Profile

Global Rank

#2259

Image: U.S. Navy photo by Mass Communication Specialist 3rd Class Timothy Aguirre | Public domain | via Wikimedia Commons

John Oyler

CEO, Biotech

UNITED STATES

Real-Time Net Worth

$1.761B

Estimated based on Biotech stock value as of March 6, 2026

-1.62% (24h)

Age

Source

Biotech

Industry

Healthcare

Citizenship

UNITED STATES

Biography

John Oyler is the CEO and co-founder of BeOne Medicines. With a current net worth of $1.0 billion, Oyler has built his wealth in the biotech industry. He is a key shareholder in BeOne Medicines, and his leadership has been instrumental in the company's growth and mission to expand access to high-quality cancer therapies globally. Oyler's career includes successful ventures such as Telephia and BioDuro, demonstrating his consistent entrepreneurial drive and strategic vision. He holds an MBA from Stanford University and a Bachelor of Science from MIT.

Fact Checked

Verified by Editorial Team

Live Data

Updated 3/6/2026

Wealth Over Time

Portfolio Holdings

BeOne Medicines

In-Depth Profile

Early Life

John Oyler was born in 1968 in Pittsburgh, Pennsylvania. His interest in science was ignited by a teacher at Mount Lebanon High School. Economic decline in Pittsburgh in the 1970s and 1980s gave Oyler an appreciation of entrepreneurship.

Rise to Success

Oyler began his career at McKinsey & Company and later earned an MBA from Stanford University. He co-founded BeiGene in 2010. Oyler's vision was to build a global biotechnology company focused on developing cancer medicines and expanding access to them. His previous ventures include Telephia, a consumer telecom research firm he founded in 1997, and BioDuro, a drug discovery outsourcing company founded in 2005.

Key Business Strategies

Oyler has focused on building a global biotechnology company, especially in the oncology field. He has emphasized the importance of clinical trials and building a sustainable business model. BeiGene, now known as BeOne Medicines, aims to bring affordable and accessible products to the market.

Philanthropy

Information on specific philanthropy initiatives and amounts are unavailable in the search results.

Career Milestones

1997

Founded Telephia, Inc.

Founded Telephia, a consumer telecom research firm.

1997

Co-Chief Executive Officer of Genta Incorporated

Served as Co-Chief Executive Officer of Genta Incorporated, an oncology focused biopharmaceutical company.

2005

Founded BioDuro, LLC

Founded BioDuro, a drug discovery outsourcing company.

2010

Cofounded BeiGene (Now BeOne Medicines)

Cofounded BeiGene, a biotechnology company focused on cancer treatments.

Philanthropy & Social Impact

REAL initiative

$XB

REAL description

Business Philosophy & Leadership

Notable Quotes

""We need to be more affordable everywhere across the world and I think when we do that our industry shifts from an industry that really has only cared about getting innovative impactful medicines to the wealthiest.""

Leadership Principles

Passion and Hard Work

If he wants his team to be passionate and work hard, he needs to embody those qualities.

Communication

Incredibly important to communicate what is happening to everyone in the organization.

Controversies & Challenges

YEAR

REAL controversy

REAL description

Compare John Oyler

Net Worth Face-off

John Oyler vs Elon Musk

Compare Wealth →

Net Worth Face-off

John Oyler vs Jeff Bezos

Compare Wealth →

Net Worth Face-off

John Oyler vs Mark Zuckerberg

Compare Wealth →